🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, Phase II interventional study in order to assess eff...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-11-23
Trial ID
NCT04508647
Treatments Being Tested
This phase IIa trial studies the side effects and how well TGR-1202 and ibr...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2016-10-07
Trial ID
NCT02874404
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of TG...
Status
Completed
Location
TG Therapeutics Investigational Trial Site
Start Date
2014-06-11
Trial ID
NCT02164006
Treatments Being Tested
This is a phase 2, open label study to assess umbralisib in combination wit...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2019-07-10
Trial ID
NCT03828448
Treatments Being Tested
This research is being done to assess Umbralisib and Rituximab as a first l...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2019-09-01
Trial ID
NCT03919175
Treatments Being Tested
This study evaluates the efficacy and safety of umbralisib and ublituximab ...
Status
Terminated
Location
Weill Cornell Medicine
Start Date
2021-02-10
Trial ID
NCT04149821
Treatments Being Tested
Phase I/II Study of Venetoclax or Lenalidomide in Combination with Ublituxi...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2018-03-27
Trial ID
NCT03379051
Treatments Being Tested
This is a Phase 1, open-label, study of TGR-1202, a PI3K delta inhibitor, a...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2015-07
Trial ID
NCT02493530
Treatments Being Tested
This is a single arm, multi-center, open label Phase Ib/II trial in adult p...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2021-08-31
Trial ID
NCT04692155
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of TG...
Status
Completed
Location
TG Therapeutics Trial Site
Start Date
2013-01-07
Trial ID
NCT01767766
Treatments Being Tested